ライフサイエンスコーパス: pancreatic insufficiency

1 y disease leading to pain, maldigestion, and pancreatic insufficiency.

2 ly characterized by neutropenia and exocrine pancreatic insufficiency.

3 the parenchyma, fibrosis, pancreatitis, and pancreatic insufficiency.

4 ects were children aged 6-8 y who had CF and pancreatic insufficiency.

5 rotein and mRNA levels, thus suggesting mild pancreatic insufficiency.

6 ion of patients with deltaF508 genotypes and pancreatic insufficiency.

7 these mice died within 3 weeks of birth from pancreatic insufficiency.

8 o progressive diabetes mellitus and exocrine pancreatic insufficiency.

9 r preschoolers aged 2 to 6 years with CF and pancreatic insufficiency.

10 the genders in these parameters, as well as pancreatic insufficiency, age at diagnosis, mode of pres

11 direct and indirect costs, quality of life, pancreatic insufficiency, alternative pain scales, lengt

12 inherited disorder characterized by exocrine pancreatic insufficiency and bone marrow failure.

13 late had a significantly lower prevalence of pancreatic insufficiency and CF-related diabetes, and be

14 recessive disorder characterized by exocrine pancreatic insufficiency and hematopoietic dysfunction,

15 5-10 y with CF, mild pulmonary disease, and pancreatic insufficiency and of 26 healthy control child

16 or (CFTR) gene mutations are associated with pancreatic insufficiency and pancreatitis.

17 ctal metaplasia occur, culminating in marked pancreatic insufficiency and the development of pancreat

18 llow-up period, especially the children with pancreatic insufficiency and those who were homozygous f

19 infection, in combination with correction of pancreatic insufficiency and undernutrition by multidisc

20 rioperative morbidity, a substantial risk of pancreatic insufficiency, and may overtreat noninvasive

21 No patients had endocrine or exocrine pancreatic insufficiency, and none required chronic anal

22 enital onset with sequelae of early exocrine pancreatic insufficiency as in the diseases of cystic fi

23 ciency and subjects with cystic fibrosis and pancreatic insufficiency, as compared with values in hea

24 ltisystem disorder characterized by exocrine pancreatic insufficiency, bone marrow dysfunction, and m

25 me assembly and are associated with exocrine pancreatic insufficiency, chronic neutropenia and skelet

26 c colitis, steatorrhea secondary to exocrine pancreatic insufficiency, dietary lactose or fructose ma

27 tants reported to be associated with CF with pancreatic insufficiency do not support HCO3- transport,

28 zing inflammatory disease that can result in pancreatic insufficiency due to acinar atrophy and fibro

29 in the use of diagnostic tests for exocrine pancreatic insufficiency (EPI) confound interpretation o

30 For 1010 subjects with pancreatic insufficiency, genome-wide significant linkag

31 BMI-z(5to10) was negatively correlated with pancreatic insufficiency, history of meconium ileus, and

32 Pancreatic insufficiency in cystic fibrosis (CF), even w

33 and acinar cell loss may be responsible for pancreatic insufficiency in Jagged1-deficient mice and,

34 to 6 years (mean age, 3.8 years) with CF and pancreatic insufficiency (intervention, n = 36 and contr

35 Cystic fibrosis (CF) with pancreatic insufficiency is associated with poor absorpt

36 Treatment of human exocrine pancreatic insufficiency is suboptimal.

37 Male sex, pancreatic insufficiency, meconium ileus, histamine bloc

38 ltisystem disorder characterized by exocrine pancreatic insufficiency, multilineage hematopoietic dys

39 >/=1 mo, and 38% of infants were ExFM22+) or pancreatic insufficiency (n = 70; 25% of infants were Ex

40 ticocutaneous fistula, exocrine or endocrine pancreatic insufficiency, need for additional radiologic

41 Persons with cystic fibrosis (CF) and pancreatic insufficiency (PI) are at risk of vitamin A d

42 among children with cystic fibrosis (CF) and pancreatic insufficiency (PI).

43 Risk of transplant pancreatic insufficiency, posttransplant lymphoprolifera

44 orption of fat and nitrogen in patients with pancreatic insufficiency related to cystic fibrosis.

45 is may be underappreciated, and both gut and pancreatic insufficiency represent modifiable targets in

46 sulin-treated neonatal diabetes and exocrine pancreatic insufficiency requiring enzyme replacement th

47 Two of the four patients had exocrine pancreatic insufficiency requiring replacement therapy b

48 ice are viable but have defects that include pancreatic insufficiency, similarly to UBR1-/- human pat

49 K status in subjects aged 8-25 y with CF and pancreatic insufficiency taking various vitamin K supple

50 nd adolescents with cystic fibrosis (CF) and pancreatic insufficiency, the efficacy of routine vitami

51 ille syndrome patients also display exocrine pancreatic insufficiency, the pathobiology of which is u

52 yvitamin D in 10 adults with CF and exocrine pancreatic insufficiency was compared with that of 10 he

53 Pancreatic insufficiency was managed with nutritional in

54 In infants with pancreatic insufficiency, weight z scores declined from

55 We observed endocrine/exocrine pancreatic insufficiency, which had not previously been

56 Cftr (-/-) mice have mild pancreatic insufficiency, which partially explains the b

57 or (CFTR) gene typically cause pulmonary and pancreatic insufficiency while rarely causing pancreatit